Alexander Benton Vanderzant, PA-C

Alexander Vanderzant practices at Texas Health Physicians Group in Denton, Texas.

Alexander Vanderzant's NPI, 1932657244, was assigned on September 15, 2016. Alexander Vanderzant holds Texas license PA10672.

Alexander Vanderzant's primary practice is Texas Health Physicians Group, at 2721 Panhandle St, Denton, TX 76201 in Denton County. The practice phone is (214) 860-6300.

Alexander Vanderzant's primary practice is Texas Health Physicians Group in Denton, Texas. Alexander Vanderzant is also affiliated with Texas Health Denton. The medical group on file is Texas Health Physicians Group. Dmand AI also links Alexander Vanderzant to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexander Vanderzant practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Alexander Vanderzant's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Alexander Vanderzant is licensed in Texas.

Dmand AI lists acute mini-stroke (TIA), acute sinusitis, acute skin infection, ankle or foot injury, asthma, bronchitis, bursitis and chronic kidney disease among the conditions Alexander Vanderzant treats.

CMS data shows 1,037 Medicare services from Alexander Vanderzant across 11 procedure codes in 2024, for 339 Medicare patients. Medicare paid $44,519 for them. Every service was in an office.

CMS counts 339 Medicare patients who saw Alexander Vanderzant in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Alexander Vanderzant's median patient age at 63, with 50% women.

In 2024, Alexander Vanderzant wrote 758 Medicare Part D claims for 335 patients. 88% of them were for generic drugs. CMS names the drug for 442 of them, across 18 drugs with 11 or more claims each, at $7,394 in total drug cost.

Alexander Vanderzant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexander Vanderzant as offering telehealth.

CMS Open Payments shows 5 general payments to Alexander Vanderzant from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $21.